In the most recent Webinar in late June, Stephen Becker refers to BP being risk averse and names a few but sounds like Gilead is the main target for BIT with various BP having varying levels of risk aversion.
In simple terms, can BIT provide enough data to satisfy BP that the drug is safe.
What is the value of BIT-225?, page-12
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.001(2.63%) |
Mkt cap ! $17.59M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $11.54K | 604.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1466986 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 830622 | 7 |
View Market Depth
| Last trade - 15.55pm 15/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |